Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia

The present study investigate the role of growth hormone (GH) in the pathophysiology of prostate and the role of insulin like growth factor I (IGF-I) as a risk factor in aged male patients with prostate cancer (PCa) and benign prostatic hyperplasia (BPH). For this purpose, 40 patients with PCa and B...

Full description

Bibliographic Details
Main Authors: Intissar N. Waheed, Shilan M. Ra’uf Salh
Format: Article
Language:English
Published: University of Zakho 2016-12-01
Series:Science Journal of University of Zakho
Subjects:
Online Access:https://sjuoz.uoz.edu.krd/index.php/sjuoz/article/view/417
_version_ 1818753843055296512
author Intissar N. Waheed
Shilan M. Ra’uf Salh
author_facet Intissar N. Waheed
Shilan M. Ra’uf Salh
author_sort Intissar N. Waheed
collection DOAJ
description The present study investigate the role of growth hormone (GH) in the pathophysiology of prostate and the role of insulin like growth factor I (IGF-I) as a risk factor in aged male patients with prostate cancer (PCa) and benign prostatic hyperplasia (BPH). For this purpose, 40 patients with PCa and BPH (54-85 yr.), and 10 control subjects (47-75 yr.) confirmed by digital rectal examination (DRE) and prostate specific antigen (PSA) levels, were enrolled in this study. Blood samples and biopsies were collected from cases while for the control, only blood sera were used. Gleason grading system was used to determine histological pattern of Hematoxylin and Eosin stained sections. Sera GH and IGF-I were measured for all the samples using (ELISA) technique. Biopsy results revealed that 10 cases were identified as PCa with different Gleason grades (3, 4, and 5) depending on five histological patterns, and 30 cases were identified as BPH. Compared with control values, GH level was significantly higher (P< 0.05) in PCa and BPH patients, with no significant differences between PCa and BPH groups (P> 0.05) concerning serum GH level. Statistical analysis also indicates that serum levels of IGF-I was higher and significantly (P< 0.05) associated with PCa compared with controls. Serum IGF-I also showed significant difference between control and BPH patients, and between BPH and PCa patients. The present study demonstrated that the association between serum IGF-I levels and PCa was highly significant in age 60 and declined with the age (p= 0.047), but in concern to the histological grade, IGF-I showed no significant differences (p=0.894) with the progression of disease. In conclusion it's appeared that, IGF-I play an important role in the etiology of PCa and BPH.
first_indexed 2024-12-18T05:13:47Z
format Article
id doaj.art-5ceba7a67aad4525be9e464d95c43d30
institution Directory Open Access Journal
issn 2663-628X
2663-6298
language English
last_indexed 2024-12-18T05:13:47Z
publishDate 2016-12-01
publisher University of Zakho
record_format Article
series Science Journal of University of Zakho
spelling doaj.art-5ceba7a67aad4525be9e464d95c43d302022-12-21T21:19:48ZengUniversity of ZakhoScience Journal of University of Zakho2663-628X2663-62982016-12-0142177186417Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasiaIntissar N. Waheed0Shilan M. Ra’uf Salh1University of ZakhoSulaimani UniversityThe present study investigate the role of growth hormone (GH) in the pathophysiology of prostate and the role of insulin like growth factor I (IGF-I) as a risk factor in aged male patients with prostate cancer (PCa) and benign prostatic hyperplasia (BPH). For this purpose, 40 patients with PCa and BPH (54-85 yr.), and 10 control subjects (47-75 yr.) confirmed by digital rectal examination (DRE) and prostate specific antigen (PSA) levels, were enrolled in this study. Blood samples and biopsies were collected from cases while for the control, only blood sera were used. Gleason grading system was used to determine histological pattern of Hematoxylin and Eosin stained sections. Sera GH and IGF-I were measured for all the samples using (ELISA) technique. Biopsy results revealed that 10 cases were identified as PCa with different Gleason grades (3, 4, and 5) depending on five histological patterns, and 30 cases were identified as BPH. Compared with control values, GH level was significantly higher (P< 0.05) in PCa and BPH patients, with no significant differences between PCa and BPH groups (P> 0.05) concerning serum GH level. Statistical analysis also indicates that serum levels of IGF-I was higher and significantly (P< 0.05) associated with PCa compared with controls. Serum IGF-I also showed significant difference between control and BPH patients, and between BPH and PCa patients. The present study demonstrated that the association between serum IGF-I levels and PCa was highly significant in age 60 and declined with the age (p= 0.047), but in concern to the histological grade, IGF-I showed no significant differences (p=0.894) with the progression of disease. In conclusion it's appeared that, IGF-I play an important role in the etiology of PCa and BPH.https://sjuoz.uoz.edu.krd/index.php/sjuoz/article/view/417Prostate cancerBenign prostatic hyperplasiaGrowth hormoneInsulin like growth factor I
spellingShingle Intissar N. Waheed
Shilan M. Ra’uf Salh
Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
Science Journal of University of Zakho
Prostate cancer
Benign prostatic hyperplasia
Growth hormone
Insulin like growth factor I
title Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
title_full Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
title_fullStr Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
title_full_unstemmed Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
title_short Growth hormone and Insulin like growth factor -1 in relation to prostate cancer and benign prostatic hyperplasia
title_sort growth hormone and insulin like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
topic Prostate cancer
Benign prostatic hyperplasia
Growth hormone
Insulin like growth factor I
url https://sjuoz.uoz.edu.krd/index.php/sjuoz/article/view/417
work_keys_str_mv AT intissarnwaheed growthhormoneandinsulinlikegrowthfactor1inrelationtoprostatecancerandbenignprostatichyperplasia
AT shilanmraufsalh growthhormoneandinsulinlikegrowthfactor1inrelationtoprostatecancerandbenignprostatichyperplasia